The DOI matches its Crossref record; 237 of the 237 references it cites were found in a registry or an index.
Histone Modifications and Non-Coding RNAs: Mutual Epigenetic Regulation and Role in Pathogenesis
Open accessAbstract
In the last few years, more and more scientists have suggested and confirmed that epigenetic regulators are tightly connected and form a comprehensive network of regulatory pathways and feedback loops. This is particularly interesting for a better understanding of processes that occur in the development and progression of various diseases. Appearing on the preclinical stages of diseases, epigenetic aberrations may be prominent biomarkers. Being dynamic and reversible, epigenetic modifications could become targets for a novel option for therapy. Therefore, in this review, we are focusing on histone modifications and ncRNAs, their mutual regulation, role in cellular processes and potential clinical application.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
Items 201–237 of 237
Zheng, Z., Zhang, S., Chen, J., Zou, M., Yang, Y., Lu, W., Ren, S., Wang, X., Dong, W., Zhang, Z., et al. (2022) · Clinical Science · doi:10.1042/cs20210470 · Cited by 30
Wiersma, M., Bussière, M., Halsall, J. A., Turan, N., Slany, R. K., Turner, B. M., & Nightingale, K. P. (2016) · Epigenetics & Chromatin · doi:10.1186/s13072-016-0103-3 · Cited by 29
Yuan, Z., Bian, Y., Ma, X., Tang, Z., Chen, N., & Shen, M. (2019) · Stem Cells and Development · doi:10.1089/scd.2019.0014 · Cited by 29
Targeting EZH 2 as a novel therapeutic strategy for sorafenib‐resistant thyroid carcinoma
Wang, Z., Dai, J., Yan, J., Zhang, Y., & Yin, Z. (2019) · Journal of Cellular and Molecular Medicine · doi:10.1111/jcmm.14365 · Cited by 29
Zhang, H., Zhu, D., Zhang, Z., Kaluz, Š., Yu, B., Devi, N. S., Olson, J. J., & Meir, E. G. V. (2019) · Oncogene · doi:10.1038/s41388-019-1067-0 · Cited by 28
Chen, L., Jia, J., Zang, Y., et al. (2019) · Neoplasma · doi:10.4149/neo_2018_180811n611 · Cited by 27
Functional Analysis of HDACs in Tumorigenesis
Hadley, M. M., Noonepalle, S. K. R., Banik, D., & Villagra, A. (2019) · Methods in molecular biology · doi:10.1007/978-1-4939-9434-2_17 · Cited by 26
Yu, Y., Chen, Q., Zhang, X., Yang, J., Lin, K., Ji, C., Xu, A., Yang, L., & Miao, L. (2020) · Cancer Science · doi:10.1111/cas.14447 · Cited by 26
Zhang, H., Yan, T., Liu, Z., Wang, J., Lu, Y., Li, D., & Liang, W. (2017) · Journal of Cellular Biochemistry · doi:10.1002/jcb.26259 · Cited by 25
Structural heterogeneity of the mammalian polycomb repressor complex in immune regulation
Kang, S. J., & Chun, T. (2020) · Experimental & Molecular Medicine · doi:10.1038/s12276-020-0462-5 · Cited by 24
Histone deacetylase‑2: A potential regulator and therapeutic target in liver disease (Review)
Liu, Y.-R., Wang, J., Huang, Z., Chen, R.-N., Cao, X., Zhu, D., Yu, H., Wang, X., Zhou, H.-Y., Xia, Q., et al. (2021) · International Journal of Molecular Medicine · doi:10.3892/ijmm.2021.4964 · Cited by 24
Bai, S., Xiong, X., Tang, B., Ji, T., Li, X., Qu, X., & Li, W.-L. (2021) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2021/8814163 · Cited by 24
Wu, X., Shen, J., Xiao, Z., Li, J., Zhao, Y., Zhao, Q., Cho, C. H., & Li, M. (2019) · Biochemical Pharmacology · doi:10.1016/j.bcp.2019.03.011 · Cited by 23
miR-766-5p Targets Super-Enhancers by Downregulating CBP and BRD4
Gen, Y., Muramatsu, T., Inoue, J., & Inazawa, J. (2021) · Cancer Research · doi:10.1158/0008-5472.can-21-0649 · Cited by 23
Sengupta, D., Deb, M., Kar, S., Parbin, S., Pradhan, N., & Patra, S. K. (2019) · Gene · doi:10.1016/j.gene.2019.04.046 · Cited by 22
JASPer controls interphase histone H3S10 phosphorylation by chromosomal kinase JIL-1 in Drosophila
Albig, C., Wang, C., Dann, G. P., Wojcik, F., Schauer, T., Krause, S., Maenner, S., Cai, W., Li, Y., Girton, J. R., et al. (2019) · Nature Communications · doi:10.1038/s41467-019-13174-6 · Cited by 22
Liao, X., Zhou, Z., & Zhang, X. (2020) · Molecular Medicine Reports · doi:10.3892/mmr.2020.11142 · Cited by 21
Zhang, Y., Shusheng, J., Hongtao, S., Zhao, S., Lan, H., Qingyuan, Z., Cheng, S., & Huang, Y. (2020) · Aging · doi:10.18632/aging.103538 · Cited by 21
Hu, X., Xiang, L., He, D., Zhu, R., Fang, J., Wang, Z., & Cao, K. (2021) · Clinical Science · doi:10.1042/cs20200908 · Cited by 21
Methylation and Noncoding RNAs in Gastric Cancer: Everything Is Connected
Bure, I. V., & Nemtsova, M. V. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22115683 · Cited by 21
Self-citationGarofoli, M., Volpicella, M., Guida, M., et al. (2020) · Cancers · doi:10.3390/cancers12092552 · Cited by 20
Chen, M., Zhou, J.-H., Wang, P., Ye, Y., Liu, Y., Zhou, J., Chen, Z., Yang, J.-K., Liao, D.-Y., Liang, Z.-J., et al. (2021) · Aging · doi:10.18632/aging.203277 · Cited by 20
DLEU1 promotes oral squamous cell carcinoma progression by activating interferon-stimulated genes
Hatanaka, Y., Niinuma, T., Kitajima, H., Nishiyama, K., Maruyama, R., Ishiguro, K., Toyota, M., Yamamoto, E., Kai, M., Yorozu, A., et al. (2021) · Scientific Reports · doi:10.1038/s41598-021-99736-5 · Cited by 20
Peritoneal Modulators of EZH2-miR-155 Cross-Talk in Endometriosis
Brunty, S., Wright, K. R., Mitchell, B. L., & Santanam, N. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22073492 · Cited by 19
Reversine induces multipotency of lineage-committed cells through epigenetic silencing of miR-133a
Kim, M., Yi, S. A., Lee, H., Bang, S. Y., Park, E., Lee, M. G., Nam, K. H., Yoo, J. H., Lee, D. H., Ryu, H.-W., et al. (2014) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2014.02.002 · Cited by 17
Tumor suppressive lncRNA MEG3 binds to EZH2 and enhances CXCL3 methylation in gallbladder cancer
Li, D.-Q., Ding, Y.-R., Che, J.-H., Su, Z., Yang, W.-Z., Xu, L., Li, Y.-J., Wang, H.-H., & Zhou, W.-Y. (2022) · Neoplasma · doi:10.4149/neo_2022_210726n1046 · Cited by 17
Targeting histone deacetylases in endometrial cancer: a paradigm-shifting therapeutic strategy?
Garmpis, N., Damaskos, C., Garmpi, A., et al. (2018) · PubMed · doi:10.26355/eurrev_201802_14376 · Cited by 16
Fan, W., Wen, X., JinFeng, Z., Wang, K., Qiu, H., Zhang, J., & Su, F. (2020) · Artificial Cells Nanomedicine and Biotechnology · doi:10.1080/21691401.2020.1773487 · Cited by 16
Yang, D., Xu, T., Fan, L., Liu, K., & Li, G. (2021) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/s13046-020-01804-7 · Cited by 16
Long Noncoding RNAs and Their Role in Oncogenesis
Bure, I. V., Kuznetsova, E., & Zaletaev, D. V. (2018) · Molecular Biology · doi:10.1134/s0026893318060031 · Cited by 15
Self-citationBao, B., Rodríguez-Meléndez, R., & Zempleni, J. (2011) · The Journal of Nutritional Biochemistry · doi:10.1016/j.jnutbio.2011.03.007 · Cited by 14
Xia, K., Yu, L., Huang, X., Zhao, Z., & Liu, J. (2022) · World Journal of Stem Cells · doi:10.4252/wjsc.v14.i1.92 · Cited by 14
MiR‐137 inhibits cell proliferation in acute lymphoblastic leukemia by targeting JARID1B
Huang, Y., Zou, Y., Zheng, R., & Ma, X. (2019) · European Journal Of Haematology · doi:10.1111/ejh.13276 · Cited by 13
Targeting epigenetics and lncRNAs in liver disease: From mechanisms to therapeutics
Peng, X., Huang, S.-F., Chen, L., Xu, L., & Ye, W.-C. (2021) · Pharmacological Research · doi:10.1016/j.phrs.2021.105846 · Cited by 13
Non-coding RNAs-EZH2 regulatory mechanisms in cervical cancer: The current state of knowledge
Zheng, J., & Chen, L. (2021) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2021.112123 · Cited by 13
Длинные некодирующие РНК и их роль в онкогенезе
Bure, I. V., Kuznetsova, E., & Zaletaev, D. V. (2018) · Molecular Biology · doi:10.1134/s0026898418060034 · Cited by 12
Self-citationSingh, S., Bahal, R., & Rasmussen, T. P. (2020) · Experimental Cell Research · doi:10.1016/j.yexcr.2020.112216 · Cited by 8
Cited by
Kamrani, S., Naseramini, R., Khani, P., Razavi, Z. S., Afkhami, H., Atashzar, M. R., Nasri, F., Alavimanesh, S., Saeidi, F., & Ronaghi, H. (2025) · Cancer Cell International · doi:10.1186/s12935-025-03741-x · Cited by 27
“…of alteration include methylation of DNA, changes of histones (acetylation, methylation, phosphorylation, ubiquitination, and sumoylation), and non-coding RNAs, such as RNA interacting with piwi (piRNA), microRNA (miRNA), long non-coding RNA (lncRNA), and small interfering RNA (siRNA) [132, 133].”
Fibromyalgia: are you a genetic/environmental disease
Ablin, J. N. (2025) · PAIN Reports · doi:10.1097/pr9.0000000000001256 · Cited by 7
Metadata
- Authors
- Bure, I. V., Nemtsova, M. V., & Kuznetsova, E. B.
- Venue
- International Journal of Molecular Sciences
- Publisher
- MDPI AG
- Published
- 2022-05-22
- Volume
- 23
- Issue
- 10
- Pages
- 5801
- ISSN
- 1422-0067 (ISSN-L)
- OpenAlex
- W4281262016
- Cited by
- 253
- References
- 237
- FWCI
- 11.88
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.